Velegraki Magdalini, Trikola Artemis, Vasiliadis Konstantinos, Fragaki Maria, Mpitouli Afroditi, Dimas Ioannis, Voudoukis Evangelos, Giannikaki Elpida, Kapranou Amalia, Kordelas Athanasios, Stefanidis Gerasimos, Paspatis Gregorios A
Department of Gastroenterology, Venizeleion General Hospital, Heraklion, Crete (Magdalini Velegraki, Maria Fragaki, Afroditi Mpitouli, Ioannis Dimas, Evangelos Voudoukis, Gregorios A. Paspatis).
Department of Gastroenterology, Athens Naval Hospital, Athens (Artemis Trikola, Konstantinos Vasiliadis, Gerasimos Stefanidis).
Ann Gastroenterol. 2019 Sep-Oct;32(5):482-488. doi: 10.20524/aog.2019.0392. Epub 2019 Jun 10.
Endoscopic full-thickness resection (EFTR) using the full-thickness resection device (FTRD) is an invasive treatment for colorectal lesions not resectable by conventional endoscopic techniques. This study presents the first Greek experience of the FTRD procedure, assessing the efficacy and safety of EFTR.
We conducted a retrospective analysis of 17 consecutive patients treated with the FTRD at 2 referral centers from October 2015 through December 2018. The indications included difficult adenomas (non-lifting and/or at difficult locations), early adenocarcinomas and subepithelial tumors. Primary endpoints were technical success and R0 resection.
Technical success and R0 resection were achieved in 82.3% procedures (14/17) and in 87.5% of those with difficult adenomas (8 patients). In the subgroup with carcinomas (n=3), the rate of technical success and R0 resection was 66.6%, while in the subgroup with subepithelial tumors (n=6) the rate was 83.3%. Technical success and R0 resection were significantly lower for lesions >20 mm vs. ≤20 mm (P=0.0429). In the 17 patients a total of 3 adverse events occurred (17.6%) and one of the patients underwent laparoscopic appendectomy because of EFTR around the appendix.
Our study showed favorable results concerning EFTR feasibility, efficacy and safety, especially for lesions ≤20 mm, non-lifting adenomas, and subepithelial tumors. Technical success, R0 resection, and adverse events rates were comparable with previously published data. Larger randomized studies are needed to better define the clinical benefit and long-term outcomes of EFTR in selected patients.
使用全层切除装置(FTRD)进行内镜全层切除术(EFTR)是一种用于常规内镜技术无法切除的结直肠病变的侵入性治疗方法。本研究展示了希腊首次使用FTRD手术的经验,评估了EFTR的有效性和安全性。
我们对2015年10月至2018年12月在2个转诊中心接受FTRD治疗的17例连续患者进行了回顾性分析。适应证包括困难腺瘤(不可提起和/或位于困难位置)、早期腺癌和上皮下肿瘤。主要终点是技术成功和R0切除。
82.3%的手术(14/17)实现了技术成功和R0切除,在困难腺瘤患者(8例)中这一比例为87.5%。在癌患者亚组(n = 3)中,技术成功和R0切除率为66.6%,而上皮下肿瘤亚组(n = 6)的这一比例为83.3%。与≤20 mm的病变相比,>20 mm的病变技术成功和R0切除率显著更低(P = 0.0429)。17例患者共发生3例不良事件(17.6%),其中1例患者因阑尾周围的EFTR而接受了腹腔镜阑尾切除术。
我们的研究显示了EFTR在可行性、有效性和安全性方面的良好结果,特别是对于≤20 mm的病变、不可提起的腺瘤和上皮下肿瘤。技术成功率、R0切除率和不良事件发生率与先前发表的数据相当。需要更大规模的随机研究来更好地确定EFTR在特定患者中的临床益处和长期结果。